PRF Technologies (PRFX) EBT (QoQ) (2020 - 2024)
PRF Technologies (PRFX) EBT (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.47 Bn | 43.51 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.56 Bn | 39.90 Bn | 2.15 Bn |
| 3 | Zoetis | 32.32 Bn | 30.65 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.07 Bn | 19.41 Bn | 683.80 Mn |
| 6 | Viatris | 18.96 Bn | 18.07 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.46 Bn | 15.07 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -31.99% |
| Mar 31, 2024 | 46.94% |
| Dec 31, 2023 | -675.81% |
| Sep 30, 2023 | 39.96% |
| Jun 30, 2023 | 6.79% |
| Mar 31, 2023 | 72.01% |
| Dec 31, 2022 | -311.83% |
| Sep 30, 2022 | -13.60% |
| Jun 30, 2022 | -10.35% |
| Mar 31, 2022 | 74.89% |
| Dec 31, 2021 | -276.64% |
| Sep 30, 2021 | -6.51% |
| Jun 30, 2021 | 18.59% |
| Mar 31, 2021 | 51.07% |
| Dec 31, 2020 | -495.29% |
| Sep 30, 2020 | -372.97% |
| Jun 30, 2020 | -12.12% |